# Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

> **NCT00003240** · PHASE3 · UNKNOWN · sponsor: **National Cancer Institute (NCI)** · enrollment: 1800 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** ifosfamide
- **DRUG:** mitomycin C
- **DRUG:** vinblastine sulfate
- **DRUG:** vindesine
- **DRUG:** vinorelbine tartrate
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003240
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1995-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003240, "Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*